Abstract
The objective of this study is to investigate the clinical markers of life-threatening Pneumocystis pneumonia (PCP) in patients with collagen vascular diseases (CVD). The patients who contracted Pneumocystis jeroveccii were retrospectively selected from our medical charts and conditions related to the patients’ death were reviewed. The findings indicated that lower levels of serum albumin and cholinesterase, increased alveolar–arterial oxygen gradient, intratracheal intubation, and necessity to treat in the intensive care unit were significantly related to deaths associated with PCP in CVD. A special attention should be paid to decreased serum albumin and cholinesterase as ominous predictors in PCP occurred in patients with CVD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arend SM, Kroon FP, van’t Wout JW (1995) Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. Arch Intern Med 155:2436–2441. doi:10.1001/archinte.155.22.2436
Russian DA, Levine SJ (2001) Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci 321:56–65. doi:10.1097/00000441-200101000-00009
Yasuoka A, Tachikawa N, Shimada K et al (1996) (1 → 3) β-d-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab Immunol 3:197–199
Saito K, Nakayamada S, Nakano K et al (2004) Detection of Pneumocystis carinii by DNA amplication in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology 43:479–485. doi:10.1093/rheumatology/keh071
Limper AH, Offord KP, Smith TF et al (1989) Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140:1204–1209
Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases. Arthritis Rheum 42:780–789. doi:10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M
Godeau B, Coutant-Perronne V, Huong DLT et al (1994) Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21:246–251
Iikuni N, Kitahama M, Ohta S et al (2006) Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Mod Rheumatol 16:282–288. doi:10.1007/s10165-006-0502-6
Ewig S, Bauer T, Schneider C et al (1995) Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J 8:1548–1553. doi:10.1183/09031936.95.08030392
Iwama A, Yoshida M, Miwa A et al (1993) Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol 51:156–160
Yoshida T, Tsushima K, Tsuchiya A et al (2005) Risk factors for hospital-acquired bacteremia. Intern Med 11:1157–1162. doi:10.2169/internalmedicine.44.1157
Sato T, Inokuma S, Maezawa R et al (2005) Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases. Mod Rheumatol 15:191–197. doi:10.1007/s10165-005-0395-9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aoki, Y., Iwamoto, M., Kamata, Y. et al. Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases. Rheumatol Int 29, 1327–1330 (2009). https://doi.org/10.1007/s00296-009-0857-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0857-z